ArticleThe Journal of clinical investigation2004

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.

Michael W-H Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.